Clin2
NCT07089381Likely a fitRecruiting

Resveratrol for rheumatoid arthritis

Rheumatic ArthritisRheumatoid Arthritis (RA) PreventionInflamationAntioxidantAnti Oxidative StressAnti AgingC Reactive ProteinMethotrexate

Treatments studied

Part of Bones, joints & muscles, Immune system & allergy, Infections, Skin clinical trials.

This study tests whether resveratrol (a natural substance found in grapes) can help control moderate-to-high rheumatoid arthritis when added to your current RA medications. It aims to see if it reduces disease activity safely.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
118 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You need a firm rheumatoid arthritis (RA) diagnosis and moderate-to-high disease activity (like joint pain and swelling).
  • You are already taking at least one stable RA medication (such as methotrexate) for the past 3 months.
  • You cannot be on biologic treatments, other anti-inflammatory drugs, or antioxidants.
  • You must not have other serious health issues like cancer, liver/kidney disease, or be a smoker or pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06724952Not yet recruiting· Phase 4
Silymarin for rheumatoid arthritis patients on methotrexate

This trial tests if adding silymarin (a herbal supplement) to standard methotrexate treatment can help people with active rheumatoid arthritis. It aims to see if it reduces joint inflammation and improves symptoms.

Al Mansurah
NCT06753565Recruiting· Phase 2
L-carnitine supplement for rheumatoid arthritis

This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.

Cairo, Demerdash
NCT07745426Recruiting· Phase 2
Comparing add-on treatments for rheumatoid arthritis

This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.

Tanta
NCT05756179Recruiting· Phase 3
Diosmin and hesperidin for mild to moderate rheumatoid arthritis

This trial tests whether two natural plant-based medicines (diosmin and hesperidin) can reduce symptoms in people with mild to moderate rheumatoid arthritis. It compares treatment outcomes to standard care to see if these supplements help control the disease.

Alexandria
NCT07433335Recruiting· Phase 1
First study of sr-878 for rheumatoid arthritis safety

This study tests a new investigational drug called SR-878 for people with rheumatoid arthritis. It aims to see if the drug is safe and tolerable. You may join if you are between 18 and 60, have RA for at least 3 months, and take a stable dose of methotrexate.

Tbilisi
NCT07262112Not yet recruiting
Exercise and diet for rheumatoid arthritis

This study tests whether combining resistance exercise (like strength training) with an anti-inflammatory diet can help reduce pain, improve daily function, and boost quality of life for people with rheumatoid arthritis.

Hear when a new Rheumatic Arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.